Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Apr 21:2021:6654229.
doi: 10.1155/2021/6654229. eCollection 2021.

Rare Histological Variants of Liver Cancer and Their Management: A Single-Institution Experience

Affiliations
Case Reports

Rare Histological Variants of Liver Cancer and Their Management: A Single-Institution Experience

Brandon Swed et al. Case Reports Hepatol. .

Abstract

Primary liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma, are a major cause of cancer-related morbidity and mortality worldwide. There are several histologically and biologically distinct subtypes of liver cancer that have previously been reported. However, literature regarding the nonsurgical management of these patients upon disease recurrence remains limited. These variants include combined HCC-cholangiocarcinoma (cHCC-CC), Epstein-Barr virus- (EBV-) associated carcinoma, undifferentiated carcinoma, and clear cell or thyroid-like variants of HCC. Here, we aim to highlight the pathologic features, clinical course, and outcomes of five patients with these unusual hepatic tumors and explain the rationale behind the choice of their systemic therapies upon disease recurrence. All patients underwent surgical resection as the standard of care for localized disease, and upon relapse, they were treated with either chemotherapy, targeted therapy, immunotherapy, or active surveillance based on the clinical context and tumor histology. These rare variants are important to recognize as they have prognostic and therapeutic implications, and there are currently insufficient data in the literature to guide further therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
The tumour showing mixed morphologic features with haphazardly arranged, irregularly shaped glands enmeshed in fibrotic stroma typical of cholangiocarcinoma (a) as well as sheet-like growth of solid cell nests and trabeculae showing morphologic and immunohistochemical evidence of hepatocellular differentiation (b).
Figure 2
Figure 2
The tumour composed of variably sized nests and trabeculae associated with desmoplasia (arrow) and hemorrhage. (a) High-grade tumour cells containing enlarged, hyperchromatic nuclei with relatively scant cytoplasm extensive necrosis. (b) The high-grade areas are positive for cytokeratin-7 and show patchy staining for arginase and Hepar-1.
Figure 3
Figure 3
This hepatocellular carcinoma containing broad trabaculae of tumour cells with abundant clear cytoplasm (a). Other high-grade areas resembling conventional hepatocellular carcinoma (b).
Figure 4
Figure 4
Sheets of tumour cells arranged in cystically dilated glands (a) that contain brightly eosinophilic secretions reminiscent of colloid (b).
Figure 5
Figure 5
Infiltrating malignant glands are intimately associated with a dense lymphoid infiltrate (a). Intraepithelial lymphocytes are also present (b) ([–12]).

Similar articles

Cited by

References

    1. Forner A., Reig M., Bruix J. Hepatocellular carcinoma. The Lancet. 2018;391(10127):1301–1314. doi: 10.1016/s0140-6736(18)30010-2. - DOI - PubMed
    1. American Cancer Society. Cancer Facts & Figures 2020. Atlanta, GA, USA: American Cancer Society; 2020.
    1. Kirstein M. M., Wirth T. C. Multimodale therapie des hepatozellulären karzinoms. Der Internist. 2020;61(2):164–169. doi: 10.1007/s00108-019-00722-x. - DOI - PubMed
    1. Zimmerman A. Tumors and Tumor-like Lesions of the Hepatobiliary Tract: General and Surgical Pathology, 1st. Geneva, Switzerland: Springer International Publishing; 2017. pp. 151–156.
    1. Stavraka C., Rush H., Ross P. Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions. Journal of Hepatocellular Carcinoma. 2018;6:11–21. doi: 10.2147/jhc.s159805. - DOI - PMC - PubMed

Publication types

LinkOut - more resources